ClinicalTrials.Veeva

Menu

Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery

T

Tanta University

Status and phase

Enrolling
Phase 3
Phase 2

Conditions

Laparoscopic Sleeve Gastrectomy
Postoperative Nausea and Vomiting
Morbid Obesity

Treatments

Drug: Baclofen Tablets

Study type

Interventional

Funder types

Other

Identifiers

NCT05516953
35647/8/22

Details and patient eligibility

About

This study aims to evaluate the possible efficacy of baclofen on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

Full description

. A total of 100 morbidly obese patients who will be scheduled for sleeve gastrectomy will be included in the study. The patients will be selected from those attending Gastrointestinal and Laparoscopic Surgery Unit, General Surgery Department, Tanta University Hospital, Tanta, Egypt. The participants will be randomized into four groups by closed envelop method

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥35 kg/m2 with the presence of comorbidity such as hypertension, arthritis, and diabetes.
  • Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥ 40 kg/m2 without comorbidity.
  • Patients fit for anesthesia and surgery.

Exclusion criteria

  • Patients with BMI >55 kg/m2.
  • Patients with previous procedures for the treatment of obesity.
  • Pregnant females and lactating women.
  • Patients with psychological or psychiatric disease
  • Administration of antiemetic medication or systemic corticosteroids within 24 hours before surgery
  • Patients who experienced vomiting within 24 hours before surgery.
  • Patients with history of alcohol or drug abuse.
  • Patients with hypersensitivity or contraindications to any of the drugs used in this study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Group 1(Control group)
No Intervention group
Description:
include 50 patients scheduled for sleeve gastrectomy
Group 2
Experimental group
Description:
which include 50 patients scheduled for sleeve gastrectomy
Treatment:
Drug: Baclofen Tablets

Trial contacts and locations

1

Loading...

Central trial contact

Aya Moussa

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems